The role of SIRT2 in cancer: A novel therapeutic target

Int J Cancer. 2020 Dec 15;147(12):3297-3304. doi: 10.1002/ijc.33118. Epub 2020 Jun 16.

Abstract

Sirtuin 2 (SIRT2) belongs to the sirtuins family. It exists in many tissues and organs of the human body and regulates a wide range of biological functions. Studies have found that the abnormal expression of SIRT2 was associated with a variety of malignant tumors. SIRT2 possesses an important role in tumorigenesis, with both tumor-promoting and tumor-suppressing function. However, the mechanisms in which SIRT2 plays the roles in cancer are still controversial. This article reviews the role and molecular mechanism of SIRT2 in tumor evolution, and provides ideas for future research in this field, to guide the targeted therapy and drug development of related malignancies.

Keywords: SIRT2; cancer; cell cycle; tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Clonal Evolution
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*
  • Sirtuin 2 / metabolism*

Substances

  • Antineoplastic Agents
  • SIRT2 protein, human
  • Sirtuin 2